Oncogenic miR‐182‐5p Targets NCOA4 to Disrupt the NCOA4‐FTH1 Axis‐Mediated Ferroptosis in Head and Neck Squamous Cell Carcinoma
Advanced Biology · 2025
DOI: 10.1002/adbi.202400832 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2025. Verfasst von Wulin Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Second Clinical Medical College, The First People's Hospital of Yinchuan, Ningxia Medical University, Yinchuan, 750001, China. Hauptthemen laut MEDLINE: Ferroptosis, MicroRNAs, Squamous Cell Carcinoma of Head and Neck, Nuclear Receptor Coactivators. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation Program of Ningxia.
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) is characterized by a high recurrence rate and poor prognosis. Ferroptosis, a regulated cell death, plays a significant role in inhibiting tumor progression. However, its role and regulatory mechanisms in HNSCC remain unclear. In this study, the expression of ferroptosis‐related molecules in HNSCC is analysed and NCOA4 and FTH1 are identified as prognostic markers. TU177 and TU686 cells are transfected with plasmids for the overexpression or knockdown of NCOA4 and FTH1. MTT assays demonstrated reduced cell viability following either NCOA4 overexpression or FTH1 knockdown alone. Concurrently, ferroptosis hallmarks such as iron overload and ROS overproduction are upregulated in these conditions. Conversely, NCOA4 knockdown or FTH1 overexpression has the opposite effects. Furthermore, miR‐182‐5p is found to be significantly upregulated in HNSCC tissues. Mechanistic studies revealed that miR‐182‐5p directly binding to the NCOA4 3′ UTR, leading to the downregulation of NCOA4 expression and suppression of NCOA4/FTH1‐mediated ferroptosis. In conclusion, the finding elucidate the role of miR‐182‐5p/NCOA4/FTH1 signaling axis in regulating ferroptosis in HNSCC and provide insights into the molecular mechanism underlying ferroptosis in HNSCC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Clinical Medical College, The First People's Hospital of Yinchuan, Ningxia Medical University, Yinchuan, 750001, China.
- College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
- Hospital of Traditional Chinese Medicine of Yinchuan, Yinchuan, 750001, China.
ORCID-Profile: Ruixia Ma
Förderung
- Natural Science Foundation Program of Ningxia
Zitieren
APA
Wen, W., Zhao, J., Zhao, W., Zhu, S., Li, Y., Wang, L., Xie, L., Liu, T., Zhang, M., & Ma, R. (2025). Oncogenic miR‐182‐5p Targets NCOA4 to Disrupt the NCOA4‐FTH1 Axis‐Mediated Ferroptosis in Head and Neck Squamous Cell Carcinoma. Advanced Biology. https://doi.org/10.1002/adbi.202400832
Vancouver
Wen W, Zhao J, Zhao W, Zhu S, Li Y, Wang L, et al. Oncogenic miR‐182‐5p Targets NCOA4 to Disrupt the NCOA4‐FTH1 Axis‐Mediated Ferroptosis in Head and Neck Squamous Cell Carcinoma. Advanced Biology. 2025. doi:10.1002/adbi.202400832
BibTeX
@article{Wen2025,
author = {Wen, Wulin and Zhao, Jia and Zhao, Wuxia and Zhu, Simin and Li, Yongchun and Wang, Le and Xie, Lina and Liu, Tian and Zhang, Mengyu and Ma, Ruixia},
title = {Oncogenic miR‐182‐5p Targets NCOA4 to Disrupt the NCOA4‐FTH1 Axis‐Mediated Ferroptosis in Head and Neck Squamous Cell Carcinoma},
journal = {Advanced Biology},
year = {2025},
doi = {10.1002/adbi.202400832}
}
EUVIMED